Research Projects & Grants

  • Single Patient, Expanded Access. IND 162739, Role: PI, Status: Approved

Default Sponsor Type

  • Investigating Health-related Quality of Life in Patients with Lupus Nephritis and IgA Nephropathy, Role: Faculty Mentor, GlomCon, (07/2024 - 06/2025) Status: Awarded
  • A Multi-site Glomular Diseases Registry, Role: PD/PI, GlomCon, (07/2024 - 06/2025) Status: Awarded

For Profit Organization

  • A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants with Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN), Role: PI, Alexion Pharmaceuticals, (08/2024 - 08/2025) Status: Approved
  • A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy, Role: PI, Otsuka Pharmaceuticals, (07/2024 - 07/2025) Status: Approved

Internal

  • Echocardiographic Features and Genotypic Variations in Autosomal Dominant Polycystic Kidney Disease, Role: PI, LLU Dept. of Medicine, (06/2024) Status: Approved
  • HRQOL in Patients with Lupus Nephritis and IgA Nephropathy, Role: PI, LLU Dept. of Medicine, (12/2023) Status: Approved
  • Evaluation of PKD diagnosis impact on the patients' quality of life, Role: PI, LLU Dept. of Medicine, (11/2023) Status: Approved
  • Distress Tolerance in Lupus Nephritis; Exploring the Impact of Acceptance on Disease Severity, Role: PI, LLU Dept. of Medicine, (09/2023) Status: Approved
  • Cardiovascular risk management in lupus nephritis and IgA nephropathy patients, Role: PI, LLU Dept. of Medicine, (03/2023) Status: Approved
  • A multi-site glomerular diseases registry, Role: PI, LLU Dept. of Medicine, (03/2021) Status: Approved
  • Assessment of kidney disease in COVID-19 patients during hospitalization and post recovery, Role: PI, LLU Dept. of Medicine, (02/2021) Status: Approved
  • Personalized AI-Powered Education for Rare Glomerular Diseases and Polycystic Kidney Disease, Role: PI, LLU Dept. of Medicine, (02/2025) Status: Approved
  • Di-PKD: A Pilot Trial of a 12-Month Targeted Dietary Intervention on Cyst Progression in Patients with Autosomal Dominant Polycystic Kidney Disease, Role: Investigator, LLU Dept. of Medicine, (02/2025) Status: Approved

Non-Profit Organization

  • Online Glomerular Diseases Fellowship Program, Role: PD/PI, American Society of Nephrology, (07/2024 - 06/2026) Status: Awarded